Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post-and pre-capillary pulmonary hypertension (Cpc-PH)

Authors
Category Primary study
JournalEuropean Heart Journal
Year 2017
This article has no abstract
Epistemonikos ID: ff377139e69c88370f3c68fcbc34edf11b879d69
First added on: Feb 09, 2025